A randomized trial and a cross-sectional analysis have found that remote patient monitoring had a positive impact on people with cancer during the COVID-19 pandemic, while a survey suggests that patients also find the approach favorable.
Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.
The booster dose of the Pfizer–BioNTech COVID-19 vaccine should not be delayed in people with cancer, suggest the results of two studies showing insufficient immunogenicity with just the first dose.